Business Description
Bangkok Genomics Innovation PCL
ISIN : THB972010003
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.99 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.48 | |||||
Interest Coverage | 20.48 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 17.96 | |||||
Beneish M-Score | -3.23 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.4 | |||||
3-Year EBITDA Growth Rate | 32.1 | |||||
3-Year EPS without NRI Growth Rate | 32.9 | |||||
3-Year FCF Growth Rate | 83.4 | |||||
3-Year Book Growth Rate | 75.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 76.13 | |||||
9-Day RSI | 75.08 | |||||
14-Day RSI | 72.36 | |||||
6-1 Month Momentum % | -50.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.96 | |||||
Quick Ratio | 5.68 | |||||
Cash Ratio | 4.67 | |||||
Days Inventory | 42.81 | |||||
Days Sales Outstanding | 40.7 | |||||
Days Payable | 20.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.31 | |||||
Operating Margin % | 13.69 | |||||
Net Margin % | 13.1 | |||||
FCF Margin % | -4.46 | |||||
ROE % | 13.3 | |||||
ROA % | 10.83 | |||||
ROIC % | 27.8 | |||||
3-Year ROIIC % | 38.63 | |||||
ROC (Joel Greenblatt) % | 34.24 | |||||
ROCE % | 12.58 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 53.71 | |||||
PE Ratio without NRI | 53.71 | |||||
Price-to-Owner-Earnings | 26.46 | |||||
PS Ratio | 7.08 | |||||
PB Ratio | 7.39 | |||||
Price-to-Tangible-Book | 7.44 | |||||
Price-to-Free-Cash-Flow | 26.12 | |||||
Price-to-Operating-Cash-Flow | 24.16 | |||||
EV-to-EBIT | 40.28 | |||||
EV-to-EBITDA | 27.31 | |||||
EV-to-Revenue | 5.5 | |||||
EV-to-FCF | 17.03 | |||||
Price-to-Graham-Number | 4.2 | |||||
Price-to-Net-Current-Asset-Value | 11.15 | |||||
Price-to-Net-Cash | 16.11 | |||||
Earnings Yield (Greenblatt) % | 2.48 | |||||
FCF Yield % | 3.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bangkok Genomics Innovation PCL Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ฿) | 154.104 | ||
EPS (TTM) (฿) | 0.094 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 72.36 | ||
14-Day ATR (฿) | 0.146498 | ||
20-Day SMA (฿) | 2.407 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (฿) | 1.67 - 5.65 | ||
Shares Outstanding (Mil) | 600 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bangkok Genomics Innovation PCL Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bangkok Genomics Innovation PCL Stock Events
Event | Date | Price(฿) | ||
---|---|---|---|---|
No Event Data |
Bangkok Genomics Innovation PCL Frequently Asked Questions
What is Bangkok Genomics Innovation PCL(BKK:BKGI)'s stock price today?
When is next earnings date of Bangkok Genomics Innovation PCL(BKK:BKGI)?
Does Bangkok Genomics Innovation PCL(BKK:BKGI) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |